Teva Pharmaceutical (TEVA) Buy, Sell or Hold

Teva Pharmaceutical (TEVA)

39.65

+0.12 (0.30%)

as of Oct 5, 2026, 7:59:59 pm Market Open.

71 watching

DON'T BUY

Beneficiaries of the branded drug companies’ losses are generic manufacturers. This one is the largest. Not sure if the timing is exactly appropriate right now, but on a longer-term perspective, this should benefit with generic drug manufacturing.

TOP PICK

This pharmaceutical is in the sweet spot. The world's largest generic drug company. Also have proprietary drugs that it has developed on its own. They have been the main beneficiary of the switch from big name patented drugs to off-patent drugs. Have about 18% of the US generics and are working towards 30% through acquisitions and generics as drugs go off patent. 1% dividend only, because it is a growth company. The stock has a long way to go.

BUY

Largest generic drug manufacturer globally. Had a bit of a correction when the head of its North American operations resigned and was replaced. He has a 2-pronged approach to the drug industry. This is his growth generic company and he owns Pfizer (PFE-N) as his value dividend play.

PAST TOP PICK

(A Top Pick Jan 9/07. Up 45,7%.) World’s largest generic drug manufacturer. Has been a major beneficiary of the majors losing patents. Still buying.

TOP PICK

A long time favourite. It is the largest generic pharmaceutical company. They will be able to benefit from the aging population and government wanting more generic prescriptions. He bought this stock in the low 30's.

BUY

The best company to own in the generics drug area.

TOP PICK

Sitting by its all-time high even in this poor market. Largest generic drug manufacturer in the world. A major beneficiary of an economic slowdown because people will switch from branded products to generics. Major beneficiary of drugs coming off patent.

PAST TOP PICK

(A Top Pick July 25/06. Up 42%.) Still a Buy. The biggest generic drug manufacturer in the world.

BUY

An Israeli generics pharmaceutical company. At these levels, it is a very interesting stock.

TOP PICK

World's largest generic drug manufacturer. Has gone from being a growth stock to a value stock. A lot more patented drugs will be coming off in 2007 and 2008.

BUY

World’s largest generic drug manufacturer. Also have their own branded drug division. Made some acquisitions and is going through some digestion, but a year from now the stock should be significantly higher.

BUY

Generic pharmaceutical company. Very well run. Lots of cash.

BUY

World’s largest generic drug manufacturer. A value stock. Has a great pipeline of new drugs coming out in the next few years, both generic and its own proprietary drugs. Pfizer’s (PFE-N) Lipitor drug does not come off patent until 2011.

BUY

World’s largest generic drug manufacturer with most sales in North America. Reported great earnings, but stock has acted poorly lately because next year’s growth is not going to be as big. Good price.

BUY

Generic drugs. Trades and about 16 X earnings. Has a lot of cash on its balance sheet. There is a lot of competition in the generic sector still expects there will be mergers. It should continue to do well.

Showing 226 to 240 of 279 entries

Most Recent Experts

Mike Vinokur, CFA, CMT, and CFP

Propellus Wealth Partners/iA Private Wealth

Bruce Murray

The Murray Wealth Group

Dennis Mitchell, CFA

Sentry Select Capital Corp

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Teva Pharmaceutical (TEVA)